NTAGI to review trial data on Serum Institute’s qHPV vaccine against cervical cancer Press Trust of India Jun 27, 2022 A separate HPV working group of the National Technical Advisory Group on Immunisation (NTAGI) had examined on 8th June the…
SII seeks market authorisation from DCGI for India’s first qHPV vaccine against cervical cancer Press Trust of India Jun 10, 2022 The firm has applied for market authorisation after completing the phase-II/III clinical trial with support of the Department of…
SII seeks government nod to manufacture and stockpile qHPV vaccine against cervical cancer Press Trust of India May 16, 2022 The firm will soon seek market authorisation as well as a manufacturing licence from the Drugs Controller General of India (DCGI)…
